Skip to content
10-Q

Quarterly Report

PHARMOS CORP

0001513160-11-000049

← back to feed
Filed
Aug 8, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 8, 2011 59.88M sh
Stockholders Equity Q2 2011 · Jun 30, 2011 $1.05M
Stockholders Equity Q2 2011 · Dec 31, 2010 $2.02M
Current Liabilities Q2 2011 · Jun 30, 2011 $144.19K
Current Liabilities Q2 2011 · Dec 31, 2010 $171.11K
Total Liabilities Q2 2011 · Jun 30, 2011 $1.14M
Total Liabilities Q2 2011 · Dec 31, 2010 $1.17M
Current Assets Q2 2011 · Jun 30, 2011 $2.18M
Current Assets Q2 2011 · Dec 31, 2010 $3.19M
Total Assets Q2 2011 · Jun 30, 2011 $2.19M
Total Assets Q2 2011 · Dec 31, 2010 $3.19M
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$1.07M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $3.55M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $4.63M
Sga Expense Q2 2011 · Jun 30, 2010 $300.49K
Sga Expense Q2 2011 · Jun 30, 2010 $639.81K
Rd Expense Q2 2011 · Jun 30, 2010 $103.36K
Rd Expense Q2 2011 · Jun 30, 2010 $226.36K
Net Income Q2 2011 · Jun 30, 2010 −$431.98K
Net Income Q2 2011 · Jun 30, 2010 −$923.36K
Operating Income Q2 2011 · Jun 30, 2010 −$404.04K
Operating Income Q2 2011 · Jun 30, 2010 −$866.81K